Skip to content

Companion supplement

All peptides
Vitamin (methylcobalamin)

B12 (Methylcobalamin)

Also known as: Methyl-B12, MeCbl, Vitamin B12 (methyl form), Mecobalamin

Vitamin B12 in the methyl form. Solid evidence for treating documented deficiency and pernicious anemia. The wellness-clinic 'energy injection' market for non-deficient adults has no clinical-trial support.

Reviewed 2026-05-04

What it does

Methylcobalamin is one of the two coenzymatically active forms of vitamin B12. It is included in this library because injectable B12 is the single most commonly stacked companion compound with peptide protocols, and because methyl-B12 supports methylation pathways that intersect with most peptide regimens. The evidence base diverges sharply by indication: replacing a documented B12 deficiency or treating pernicious anemia is straightforward nutritional medicine. Using B12 injections as a generic 'energy boost' in non-deficient adults — the wellness-clinic market — has no controlled-trial support. The category badge on this entry literally says 'NOT a peptide' — it's here as a companion, not as one.

Used for

Dose

Dose
1,000 mcg · weekly to monthly
When
MorningBioactive without conversion. Morning to avoid the energetic lift interfering with sleep onset. Sublingual / IM both fine for routine use.
Site
intramuscular or subcutaneous (replacement)

Need exact volumes? Open the peptide calculator →

⚠ Caution

  • Known hypersensitivity to cobalt or formulation excipients (rare)
  • Leber's hereditary optic neuropathy (cyanocobalamin specifically; methylcobalamin is safer in this rare condition)
  • Polycythemia vera (theoretical caution; correcting megaloblastic anemia can unmask increased red-cell mass)

Your stack

Track this peptide in your protocol — dose, schedule, vials on hand, refill projection. Stays in your browser; no account needed.

Add to my stack

Use this peptide

Featured in protocols
Reconstitution & storage

Methylcobalamin for IM/SubQ injection is typically supplied as a sterile pre-mixed solution (commonly 1 mg/mL or 5 mg/mL) — no patient reconstitution required for standard pharmacy product. Compounded formulations vary; a 1 mg/mL solution makes a standard 1000 mcg dose = 1 mL = 100 units on a U-100 syringe. Methylcobalamin is light-sensitive (reddish-pink color from the cobalt); store amber vial or away from light.

Storage. Refrigerate 2–8 °C, protect from light. Compounded multi-dose vials: use within label expiration. Some methylcobalamin formulations are stable at room temperature short-term but the methyl form degrades faster than cyanocobalamin under light/heat.

Open the peptide calculator →

Monitoring & questions

Reported side effects
  • Generally extremely well tolerated
  • Injection-site discomfort, transient erythema
  • Rare: anaphylactoid reaction (more historically associated with cyanocobalamin formulations containing aluminum)
  • Rare: acneiform eruption with high-dose injection in some users
  • Hypokalemia possible during rapid correction of severe megaloblastic anemia (treat-the-cause warning, not a routine concern)

Reference

How it works

B12 is the cofactor for two essential enzymes: methionine synthase (uses methylcobalamin to remethylate homocysteine to methionine, supporting SAMe-dependent methylation of DNA, RNA, neurotransmitters, and phospholipids) and L-methylmalonyl-CoA mutase (uses adenosylcobalamin in mitochondrial fatty acid metabolism). The methyl form is preferred by some practitioners for users with MTHFR variants, though the practical clinical relevance of MTHFR genotype to B12 form choice is contested.

Juno's take

B12 sits in the library as a companion compound because it's the most commonly stacked injection alongside peptide protocols. Two things to hold separate: replacement for documented deficiency or pernicious anemia is standard nutritional medicine going back to the 1940s — genuinely strong evidence. Using injectable B12 as an 'energy shot' in healthy non-deficient adults has no controlled-trial support whatsoever. The clinic market for that is enormous; the evidence for it is essentially placebo.

EvidenceTier 1 — Human RCT

Tiers are per indication. The same molecule can be Tier 1 for one use and Tier 4 for another — the tier reflects published literature, not community framing.

Vitamin B12 deficiency / pernicious anemia

Tier 1high confidence

Standard nutritional medicine since the 1940s. IM/SubQ replacement reverses megaloblastic anemia and neurological deficits. WHO and national guidelines recommend parenteral B12 for symptomatic deficiency and for malabsorption (intrinsic factor deficiency, post-bariatric, ileal disease).

Devalia V et al. 2014

B12 deficiency on metformin / PPI / vegan diet

Tier 1high confidence

Documented increased risk of B12 deficiency on chronic metformin (Aroda et al., DPPOS) and PPI use, and in long-term vegans. Replacement is well established; the Tier 1 evidence is for replacement specifically when deficiency is documented or strongly suspected by lab markers (B12, MMA, homocysteine).

Aroda VR et al. 2016

Subacute combined degeneration of the spinal cord

Tier 1high confidence

Established neurological complication of severe B12 deficiency; parenteral repletion is the treatment of record.

Devalia V et al. 2014

Generic 'energy boost' in non-deficient adults (wellness-clinic IM)

Tier 3high confidence

There is no published RCT showing that B12 injections in non-deficient adults improve energy, cognition, or fatigue. The IM/IV B12 market in wellness clinics rests almost entirely on placebo and the experience of being injected. Hold this Tier 3 firmly, despite massive consumer-clinic volume.

No primary citations are anchored to this indication — the tier reflects the absence of usable literature, not a missing reference.

Cognitive function / dementia prevention in normal-B12 elderly

Tier 3high confidence

B12 supplementation in adults without documented deficiency has not been shown to prevent cognitive decline in well-designed RCTs (e.g., VITACOG and others). Replacement IS warranted when deficiency is found; supplementation as a general cognitive intervention is not supported.

No primary citations are anchored to this indication — the tier reflects the absence of usable literature, not a missing reference.

Diabetic peripheral neuropathy (high-dose methylcobalamin)

Tier 2medium confidence

Multiple Asian RCTs of high-dose oral or parenteral methylcobalamin in diabetic neuropathy show modest symptom improvement. Studies are heterogeneous and effect sizes modest. Tier 2 with appropriate caveats.

Jayabalan B et al. 2016
Citations (3)
  1. [1]
    Guidelines for the diagnosis and treatment of cobalamin and folate disorders
    Devalia V, Hamilton MS, Molloy AM · British Journal of Haematology · 2014 · PMID 24942828
    Anchor guideline reference for Tier 1 deficiency / pernicious anemia indication.
    View source
  2. [2]
    Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study
    Aroda VR, Edelstein SL, Goldberg RB, et al. · Journal of Clinical Endocrinology & Metabolism · 2016 · PMID 26900641
    Tier 1 anchor for the metformin-related B12 deficiency indication; large prospective dataset (DPPOS).
    View source
  3. [3]
    Cobalamin supplementation in the treatment of painful diabetic neuropathy: a systematic review and meta-analysis
    Jayabalan B, Low LL. · Singapore Medical Journal · 2016 · PMID 27293795
    Anchor for the Tier 2 diabetic peripheral neuropathy indication; mixed evidence with modest effect sizes.
    View source